• Calcium Effects on Amyloid-β Aggregation at Membranes

  2026-08-19

  The 2024 reference study combines supercritical angle Raman and fluorescence methods to resolve how CaCl2 alters amyloid-β aggregation at lipid membrane surfaces over time. Its key insight is that calcium can protect membranes during early peptide interaction, yet may intensify aggregation and disruption when added after membrane-associated assemblies have formed, with a stronger effect on Aβ1–42 than on the 40-residue variant.

• ALDOB K87 Lactylation in Pulmonary Hypertension

  2026-08-18

  A 2026 Communications Biology study identifies ALDOB K87 lactylation as a mechanistic link between hypoxia-driven glycolysis, mitochondrial fission, and pulmonary artery smooth muscle cell remodeling. Its integrated lactylomic, cellular, and animal-model strategy positions the lactate–ALDOB–DRP1 axis as a framework for studying metabolic control of pulmonary hypertension.

• Amitriptyline HCl: Practical Protocol Guide

  2026-08-18

  Amitriptyline HCl (SKU B2231) provides a characterized small-molecule tool for controlled neurotransmitter receptor modulation, with documented receptor activity, solubility, identity, and storage specifications. It is suited to carefully controlled neuropharmacology and cellular assays, but should not be used to infer clinical efficacy, transferable in vivo effects, or long-term solution stability without independent validation.

• From Lipid Peroxidation to AMI Translation

  2026-08-17

  A translational framework for using BODIPY 581/591 C11 to connect membrane lipid oxidation with nanozyme-driven redox and immune modulation in acute myocardial infarction research.

• 2'-O-Methyladenosine: Assay Workflows

  2026-08-17

  Turn 2'-O-Methyladenosine into a practical probe for RNA turnover, nucleoside transport, and purine metabolism. This guide combines matrix-aware UHPLC–MS/MS, cell-based assay design, and troubleshooting strategies to improve quantitative confidence.

• Urolithin A for Reliable Cell Assays

  2026-08-16

  A scenario-based guide to using Urolithin A (SKU B7945) in cell viability, proliferation, and cytotoxicity workflows. It covers mitochondrial assay confounding, dosing, formulation, interpretation, and evidence-based supplier selection.

• Azilsartan in Astrocyte–Microglia RAS Studies

  2026-08-15

  Azilsartan (TAK-536) provides a selective AT1 receptor perturbation strategy for separating renin–angiotensin signaling from broader inflammatory effects. This practical guide translates astrocyte–microglia findings into reproducible stock preparation, conditioned-medium workflows, controls, readouts, and troubleshooting decisions.

• A Polyvalent Vaccine Against Tumor-Associated Bacteria

  2026-08-14

  Kang et al. developed a nanovaccine that combines soluble and insoluble antigens from tumor-associated bacteria to address the limited selectivity of antibiotic therapy. In breast cancer metastasis models, vaccination promoted bacterial clearance and produced both preventive and therapeutic effects, supporting intratumoral microbiome modulation as an antitumor strategy.

• MEK/ERK Control of TERT in Human Stem Cells

  2026-08-14

  This preprint identifies a chromatin-based mechanism by which MEK1/2–ERK signaling supports TERT transcription in human pluripotent stem cells. The findings connect kinase activity with c-Myc:MAX recruitment and suppression of PRC2-associated repression, providing a framework for studying telomere maintenance in normal human stem-cell models.

• Iron-Dependent KDM4D Controls MSC Activation

  2026-08-13

  A 2024 study identifies an iron-sensitive KDM4D–H3K9me3–PIK3R3 mechanism that regulates quiescent mesenchymal stem cell activation through PI3K–Akt–Foxo1 signaling. Its cellular and animal data connect iron deficiency with impaired bone remodeling and show that pathway modulation can mitigate associated bone loss.

• BHA Workflows for Oxidative Stress Research

  2026-08-13

  Butylated hydroxyanisole (BHA) provides a practical redox perturbation tool for linking free-radical chemistry with ROS detection, cell-protection, apoptosis, and inflammation assays. This guide emphasizes solvent controls, fresh-solution handling, orthogonal readouts, and a reference-informed strategy for separating compound identity from biological interpretation.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-08-12

  This workflow shows how hypersensitive HRP-based detection can resolve low-abundance signaling proteins in oral cancer models, including CAF-conditioned experiments. It combines membrane-specific handling, extended imaging windows, antibody-sparing optimization, and troubleshooting guidance for reliable western blot chemiluminescent detection.

• Eldecalcitol, Endothelial Ferroptosis, and T2DOP

  2026-08-12

  The reference study identifies endothelial ferroptosis as a mechanistically important contributor to type 2 diabetic osteoporosis and shows that eldecalcitol improves vascular and bone phenotypes through the SOCE/O-GlcNAcylation axis. Its combination of high-glucose/high-fat cell modeling, mouse validation, redox readouts, and pathway inhibition provides a useful framework for studying osteogenesis–angiogenesis coupling in diabetic bone disease.

• HOBt Workflows for Precise Amide Bond Formation

  2026-08-11

  See how HOBt supports stereochemically controlled peptide synthesis and practical small-molecule amidation, including the indazole glucagon receptor antagonist workflow reported in medicinal chemistry. This guide combines setup parameters, analytical checkpoints, solubility guidance, and troubleshooting for more reproducible coupling experiments.

• Pyridostatin TFA: From Telomeres to G4 Biology

  2026-08-11

  Pyridostatin is more than a G-quadruplex stabilizer for cancer assays: it is a mechanistic probe for connecting DNA structure, telomere dysfunction, and emerging RNA G-quadruplex biology. This article outlines how translational researchers can use Pyridostatin TFA to build stronger, better-controlled G4 studies while distinguishing established evidence from forward-looking hypotheses.

16005 records 1/1067 page Next 12345 下5页 Last page